Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-09-18 Sale | 2020-09-22 8:02 pm | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 5,000 | $99.98 | $499,918 | 131,196 (Indirect Direct) | View |
| 2020-08-18 Sale | 2020-08-20 8:17 pm | Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer | 15,000 | $100 | $1,500,000 | 169,883 (Direct) | View |
| 2020-08-18 Sale | 2020-08-20 8:01 pm | Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y Chief Financial Officer | 7,500 | $99.37 | $745,240 | 63,823 (Indirect Direct) | View |
| 2020-08-10 Sale | 2020-08-12 8:01 pm | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 6,000 | $88.61 | $531,665 | 44,699 (Direct) | View |
| 2020-07-15 Sale | 2020-07-17 8:01 pm | Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer | 15,000 | $80.07 | $1,201,070 | 184,883 (Direct) | View |
| 2020-07-01 Sale | 2020-07-02 8:48 pm | Principia Biopharma Inc. | PRNB | Colowick Alan Director | 7,500 | $60 | $450,000 | 47,724 (Direct) | View |
| 2020-06-23 Sale | 2020-06-25 8:07 pm | Principia Biopharma Inc. | PRNB | Babler Martin President, CEO | 15,000 | $61.86 | $927,889 | 144,072 (Indirect Direct) | View |
| 2020-06-15 Sale | 2020-06-17 9:52 pm | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 5,504 | $60.75 | $334,385 | 19,096 (Direct) | View |
| 2020-03-16 Sale(A) | 2020-06-17 9:48 pm | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 5,504 | $46.15 | $254,031 | 24,600 (Direct) | View |
| 2019-12-16 Sale(A) | 2020-06-17 9:41 pm | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 5,505 | $49.43 | $272,091 | 30,104 (Direct) | View |
| 2020-06-12 Sale | 2020-06-15 8:12 pm | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 5,000 | $61.16 | $305,788 | 122,435 (Indirect Direct) | View |
| 2020-05-19 Sale | 2020-05-21 8:01 pm | Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y Chief Financial Officer | 7,500 | $65.1 | $488,268 | 71,323 (Indirect Direct) | View |
| 2020-05-07 Sale | 2020-05-08 8:05 pm | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 6,000 | $60.16 | $360,941 | 33,415 (Direct) | View |
| 2020-05-01 Sale | 2020-05-05 8:07 pm | Principia Biopharma Inc. | PRNB | Colowick Alan Director | 7,500 | $60.01 | $450,057 | 117,108 (Direct) | View |
| 2020-03-16 Sale | 2020-03-18 5:08 pm | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 5,504 | $46.15 | $254,031 | 54,656 (Direct) | View |
| 2020-03-13 Sale | 2020-03-17 5:08 pm | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 5,000 | $48.56 | $242,816 | 126,577 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-09-28 Disposition | 2020-09-28 5:29 pm | N/A 2029-08-28 | Principia Biopharma Inc. | PRNB | Tomasello Shawn Director | 30,715 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:28 pm | N/A 2029-06-10 | Principia Biopharma Inc. | PRNB | Machado Patrick Director | 40,955 | $0 | 0 (Direct) | View |
| 2020-09-28 Equity Swap | 2020-09-28 5:27 pm | N/A N/A | Principia Biopharma Inc. | PRNB | George Simeon Director | 2,982,855 | $100 | 0 (Indirect) | View |
| 2020-09-28 Disposition | 2020-09-28 5:27 pm | N/A 2022-12-29 | Principia Biopharma Inc. | PRNB | George Simeon Director | 69,578 | $0 | 0 (Indirect) | View |
| 2020-09-28 Disposition | 2020-09-28 5:25 pm | N/A 2029-04-15 | Principia Biopharma Inc. | PRNB | Lin Shao-Lee Director | 40,955 | $0 | 0 (Direct) | View |
| 2020-09-28 Equity Swap | 2020-09-28 5:24 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Becker Daniel J. Director | 667,600 | $100 | 0 (Indirect) | View |
| 2020-09-28 Disposition | 2020-09-28 5:24 pm | N/A 2028-09-12 | Principia Biopharma Inc. | PRNB | Becker Daniel J. Director | 40,955 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:21 pm | N/A 2027-06-26 | Principia Biopharma Inc. | PRNB | Colowick Alan Director | 88,679 | $0 | 0 (Direct) | View |
| 2020-09-28 Equity Swap | 2020-09-28 5:19 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 13,592 | $100 | 0 (Direct) | View |
| 2020-09-18 Gift | 2020-09-28 5:19 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 5,504 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:19 pm | N/A 2027-02-15 | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 238,958 | $0 | 0 (Direct) | View |
| 2020-09-28 Equity Swap | 2020-09-28 5:16 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer | 2,207 | $100 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:16 pm | N/A 2028-10-22 | Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer | 283,057 | $0 | 0 (Direct) | View |
| 2020-09-28 Equity Swap | 2020-09-28 5:14 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 119,677 | $100 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:14 pm | N/A 2027-12-13 | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 170,553 | $0 | 0 (Direct) | View |
| 2020-09-28 Equity Swap | 2020-09-28 5:11 pm | N/A N/A | Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y Chief Financial Officer | 7,101 | $100 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:11 pm | N/A 2023-12-11 | Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y Chief Financial Officer | 318,395 | $0 | 0 (Direct) | View |
| 2020-09-28 Equity Swap | 2020-09-28 5:08 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 31,826 | $100 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:08 pm | N/A 2024-06-26 | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 286,117 | $0 | 0 (Direct) | View |
| 2020-09-28 Equity Swap | 2020-09-28 5:07 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Babler Martin President, CEO | 58,557 | $100 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:07 pm | N/A 2022-12-29 | Principia Biopharma Inc. | PRNB | Babler Martin President, CEO | 1,048,147 | $0 | 0 (Indirect) | View |
| 2020-09-18 Exercise | 2020-09-22 8:02 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 2,242 | $7.2671 | 131,196 (Direct) | View |
| 2020-09-18 Exercise | 2020-09-22 8:02 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 2,758 | $4.7236 | 131,196 (Direct) | View |
| 2020-09-18 Exercise | 2020-09-22 8:02 pm | N/A 2025-02-25 | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 5,000 | $0 | 131,196 (Direct) | View |
| 2020-08-18 Exercise | 2020-08-20 8:17 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer | 15,000 | $23.77 | 169,883 (Direct) | View |
| 2020-08-18 Exercise | 2020-08-20 8:17 pm | N/A 2028-10-22 | Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer | 15,000 | $0 | 169,883 (Direct) | View |
| 2020-08-18 Exercise | 2020-08-20 8:01 pm | N/A N/A | Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y Chief Financial Officer | 7,500 | $2.9977 | 63,823 (Direct) | View |
| 2020-08-18 Exercise | 2020-08-20 8:01 pm | N/A 2023-12-11 | Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y Chief Financial Officer | 7,500 | $0 | 63,823 (Direct) | View |
Ownership | 2020-08-20 4:19 pm | N/A 2020-11-20 | Principia Biopharma Inc. | PRNB | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 0 | $0 | 4,893,400 (Direct) | View |
| 2020-08-10 Exercise | 2020-08-12 8:01 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 3,553 | $3.1794 | 44,699 (Direct) | View |
| 2020-08-10 Exercise | 2020-08-12 8:01 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 2,447 | $2.9977 | 44,699 (Direct) | View |
| 2020-08-10 Exercise | 2020-08-12 8:01 pm | N/A 2023-10-23 | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 6,000 | $0 | 44,699 (Direct) | View |
| 2020-07-15 Exercise | 2020-07-17 8:01 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer | 15,000 | $23.77 | 184,883 (Direct) | View |
| 2020-07-15 Exercise | 2020-07-17 8:01 pm | N/A 2028-10-22 | Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer | 15,000 | $0 | 184,883 (Direct) | View |
| 2020-07-01 Exercise | 2020-07-02 8:48 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Colowick Alan Director | 7,500 | $4.542 | 47,724 (Direct) | View |
| 2020-07-01 Exercise | 2020-07-02 8:48 pm | N/A 2027-06-26 | Principia Biopharma Inc. | PRNB | Colowick Alan Director | 7,500 | $0 | 47,724 (Direct) | View |
| 2020-06-23 Exercise | 2020-06-25 8:07 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Babler Martin President, CEO | 15,000 | $2.9977 | 144,072 (Direct) | View |
| 2020-06-23 Exercise | 2020-06-25 8:07 pm | N/A 2023-10-23 | Principia Biopharma Inc. | PRNB | Babler Martin President, CEO | 15,000 | $0 | 144,072 (Direct) | View |
| 2020-06-12 Exercise | 2020-06-15 8:12 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 5,000 | $4.7236 | 122,435 (Direct) | View |
| 2020-06-12 Exercise | 2020-06-15 8:12 pm | N/A 2025-02-25 | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 5,000 | $0 | 122,435 (Direct) | View |
| 2020-06-04 Option Award | 2020-06-08 8:12 pm | N/A 2030-06-03 | Principia Biopharma Inc. | PRNB | Tomasello Shawn Director | 10,240 | $0 | 10,240 (Direct) | View |
| 2020-06-04 Option Award | 2020-06-08 8:10 pm | N/A 2030-06-03 | Principia Biopharma Inc. | PRNB | Machado Patrick Director | 10,240 | $0 | 10,240 (Direct) | View |
| 2020-06-04 Option Award | 2020-06-08 8:08 pm | N/A 2030-06-03 | Principia Biopharma Inc. | PRNB | George Simeon Director | 10,240 | $0 | 10,240 (Direct) | View |
| 2020-06-04 Option Award | 2020-06-08 8:05 pm | N/A 2030-06-03 | Principia Biopharma Inc. | PRNB | Lin Shao-Lee Director | 10,240 | $0 | 10,240 (Direct) | View |
| 2020-06-04 Option Award | 2020-06-08 8:03 pm | N/A 2030-06-03 | Principia Biopharma Inc. | PRNB | Becker Daniel J. Director | 10,240 | $0 | 10,240 (Direct) | View |
| 2020-06-04 Option Award | 2020-06-08 8:02 pm | N/A 2030-06-03 | Principia Biopharma Inc. | PRNB | Colowick Alan Director | 10,240 | $0 | 10,240 (Direct) | View |
| 2020-05-19 Exercise | 2020-05-21 8:01 pm | N/A N/A | Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y Chief Financial Officer | 5,675 | $2.9977 | 71,323 (Direct) | View |
| 2020-05-19 Exercise | 2020-05-21 8:01 pm | N/A 2023-12-11 | Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y Chief Financial Officer | 5,675 | $0 | 71,323 (Direct) | View |
| 2020-05-07 Exercise | 2020-05-08 8:05 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 6,000 | $2.9977 | 33,415 (Direct) | View |
| 2020-05-07 Exercise | 2020-05-08 8:05 pm | N/A 2023-10-23 | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 6,000 | $0 | 33,415 (Direct) | View |
| 2020-05-01 Exercise | 2020-05-05 8:07 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Colowick Alan Director | 7,500 | $4.542 | 117,108 (Direct) | View |
| 2020-05-01 Exercise | 2020-05-05 8:07 pm | N/A 2027-06-26 | Principia Biopharma Inc. | PRNB | Colowick Alan Director | 7,500 | $0 | 117,108 (Direct) | View |
| 2020-03-16 Exercise | 2020-03-18 5:08 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 5,504 | $4.542 | 54,656 (Direct) | View |
| 2020-03-16 Exercise | 2020-03-18 5:08 pm | N/A 2027-02-15 | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 5,504 | $0 | 54,656 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-17 5:08 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 5,000 | $4.7236 | 126,577 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-17 5:08 pm | N/A 2025-02-25 | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 5,000 | $0 | 126,577 (Direct) | View |
| 2020-03-05 Option Award | 2020-03-05 5:30 pm | N/A 2030-03-04 | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 55,000 | $0 | 55,000 (Direct) | View |
| 2020-03-05 Option Award | 2020-03-05 5:28 pm | N/A 2030-03-04 | Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer | 55,000 | $0 | 55,000 (Direct) | View |
| 2020-03-05 Option Award | 2020-03-05 5:27 pm | N/A 2030-03-04 | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 55,000 | $0 | 55,000 (Direct) | View |
| 2020-03-05 Option Award | 2020-03-05 5:26 pm | N/A 2030-03-04 | Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y Chief Financial Officer | 55,000 | $0 | 55,000 (Direct) | View |